New combo therapy may help liver cancer patients reach transplant
NCT ID NCT01918683
First seen Feb 01, 2026 · Last updated May 24, 2026 · Updated 16 times
Summary
This study tests whether adding radiation therapy to a standard liver cancer treatment (chemoembolization) can better control the cancer while patients wait for a liver transplant. About 40 adults with liver cancer who are already listed for a transplant will take part. The goal is to see if the combination helps keep the cancer from growing before the transplant surgery.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEPATOCELLULAR CARCINOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Abramson Cancer Center of the University of Pennsylvania
Philadelphia, Pennsylvania, 19104, United States
-
Loyola University Medical Center
Maywood, Illinois, 60153, United States
-
Oregon Health & Science University
Portland, Oregon, 97239, United States
Conditions
Explore the condition pages connected to this study.